Trachoma - a bacterial infection that affects the eyes - is one of the oldest known infectious diseases in human history. Despite being easily preventable and treatable, trachoma still remains a significant public health concern, especially in developing countries where sanitation facilities are poor. As medical professionals, understanding trachoma and its causes is essential to effectively diagnose and treat this condition. In this comprehensive guide, we'll explore everything you need to know about trachoma: from its symptoms to its causes and treatment options. So let's dive in!
Trachoma is a bacterial infection that primarily affects the eyes, and it's caused by repeated exposure to bacteria called Chlamydia trachomatis. The symptoms of trachoma usually take between five to twelve days after exposure before they begin to appear.
In its early stages, trachoma may not present any symptoms at all. However, as the condition progresses, you may experience itching or irritation in your eyes which can lead to swelling of the eyelids and discharge from the eye.
The inflammation caused by trachoma can also cause scarring on the inner surface of your eyelid that leads to entropion - a condition where your eyelashes grow inward towards your eyeball instead of outward. This can result in further irritation and damage to your cornea leading to loss of vision if left untreated.
Remember: prevention is always better than cure when it comes to infectious diseases like Trachoma!
Trachoma is an infectious eye disease caused by the bacterium Chlamydia trachomatis. This bacterium is transmitted through contact with hands, towels or clothing of infected individuals, and flies that have come into contact with infected discharge from the eyes or nose.
The risk factors for trachoma include poor sanitation, crowded living conditions, and lack of access to clean water. The disease tends to affect young children who are more susceptible to infection due to their underdeveloped immune systems.
Repeated infections can lead to scarring on the inner surface of the eyelid which can cause them to turn inwards towards the eyeball and scratch it. In severe cases, this can lead to blindness.
Trachoma is prevalent in areas where poverty is high and access to healthcare is limited. It affects millions of people around the world but can be prevented through proper hygiene practices such as handwashing, facial cleanliness, and environmental improvements like safe water supply and improved sanitation facilities.
Trachoma is a bacterial infection that can cause blindness if left untreated. Therefore, prompt treatment is crucial to prevent permanent damage to the eyes and vision loss.
The most common treatment for trachoma is antibiotics, which can be administered orally or topically. Antibiotics are effective in killing the bacteria responsible for trachoma and preventing its spread. Azithromycin is commonly used as an oral antibiotic, while tetracycline eye ointment is often prescribed as topical treatment.
Surgery may also be necessary in advanced cases of trachoma where scarring has caused eyelids to turn inward or outward, leading to further irritation and damage. Surgical intervention involves correcting the position of the eyelid through a procedure known as entropion surgery.
In addition to medical treatments, proper hygiene practices such as frequent washing of hands and face with soap and water can help prevent the spread of trachoma.
Trachoma is a serious eye infection that affects millions of people around the world, particularly in areas with poor sanitation and limited access to healthcare. It is caused by bacteria that spread through contact with infected individuals or contaminated objects.
Symptoms of trachoma include itching, watering eyes, and a thick discharge from the eyes. In severe cases, it can lead to blindness. The good news is that trachoma can be prevented and treated.
Prevention measures include improving hygiene practices such as face washing and reducing overcrowding in living spaces. Antibiotics are also used to treat active infections.
1.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Hereditary cancer has a rare and underreported cause.
4.
New imaging guidelines for head and neck cancers, a step toward practice change
5.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
1.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
Essential Updates in Hematology in Daily Practice
4.
The Predictive Power of Theranostics in Palliative Neuroendocrine Tumor Management
5.
Importance of Early Detection in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
5.
A New Era in Managing Cancer-Associated Thrombosis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation